NO20025999D0 - Klart, vandig anestetisk preparat - Google Patents
Klart, vandig anestetisk preparatInfo
- Publication number
- NO20025999D0 NO20025999D0 NO20025999A NO20025999A NO20025999D0 NO 20025999 D0 NO20025999 D0 NO 20025999D0 NO 20025999 A NO20025999 A NO 20025999A NO 20025999 A NO20025999 A NO 20025999A NO 20025999 D0 NO20025999 D0 NO 20025999D0
- Authority
- NO
- Norway
- Prior art keywords
- propofol
- compositions
- clear
- hydroxypropyl
- beta
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Nanotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medical Informatics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biotechnology (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Inorganic Chemistry (AREA)
- Anesthesiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN573MU2000 IN187686B (fr) | 2000-06-21 | 2000-06-21 | |
| PCT/IN2000/000124 WO2001097796A1 (fr) | 2000-06-21 | 2000-12-14 | Composition anesthesique aqueuse claire |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20025999D0 true NO20025999D0 (no) | 2002-12-13 |
| NO20025999L NO20025999L (no) | 2002-12-13 |
Family
ID=11097257
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20025999A NO20025999L (no) | 2000-06-21 | 2002-12-13 | Klart, vandig anestetisk preparat |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US7138387B2 (fr) |
| EP (1) | EP1299095B1 (fr) |
| JP (1) | JP4907833B2 (fr) |
| KR (1) | KR100810066B1 (fr) |
| CN (1) | CN1254237C (fr) |
| AP (1) | AP2002002674A0 (fr) |
| AT (1) | ATE267592T1 (fr) |
| AU (2) | AU2001235972B2 (fr) |
| BG (1) | BG107463A (fr) |
| BR (1) | BR0017268A (fr) |
| CA (1) | CA2414064C (fr) |
| DE (1) | DE60011149T2 (fr) |
| DK (1) | DK1299095T3 (fr) |
| EA (1) | EA005589B1 (fr) |
| ES (1) | ES2222271T3 (fr) |
| HU (1) | HUP0301646A3 (fr) |
| IL (1) | IL153387A0 (fr) |
| IN (1) | IN187686B (fr) |
| MX (1) | MXPA02012611A (fr) |
| NO (1) | NO20025999L (fr) |
| NZ (1) | NZ523643A (fr) |
| PL (1) | PL359624A1 (fr) |
| PT (1) | PT1299095E (fr) |
| WO (1) | WO2001097796A1 (fr) |
| YU (1) | YU2703A (fr) |
| ZA (1) | ZA200300336B (fr) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IN188917B (fr) * | 2000-12-07 | 2002-11-23 | Bharat Surums & Vaccines Ltd | |
| US7034013B2 (en) | 2001-03-20 | 2006-04-25 | Cydex, Inc. | Formulations containing propofol and a sulfoalkyl ether cyclodextrin |
| ES2325918T3 (es) * | 2001-12-28 | 2009-09-24 | Eisai Corporation Of North America | Formulaciones farmaceuticas de base acuosa de profarmacos de propofol solubles en agua. |
| AU2003205930B2 (en) * | 2002-02-01 | 2007-08-16 | Shimoda Biotech (Pty) Ltd | Pharmaceutical composition |
| US7550155B2 (en) | 2002-07-29 | 2009-06-23 | Transform Pharmaceuticals Inc. | Aqueous pharmaceutical compositions of 2,6-diisopropylphenol (propofol) and their uses |
| NZ538255A (en) | 2002-07-29 | 2006-11-30 | Transform Pharmaceuticals Inc | Aqueous 2,6-diisopropylphenol pharmaceutical compositions |
| AU2003299590B8 (en) * | 2002-12-09 | 2010-04-08 | Abraxis Bioscience, Llc | Compositions and methods of delivery of pharmacological agents |
| WO2005067905A1 (fr) * | 2004-01-14 | 2005-07-28 | Otsuka Pharmaceutical Factory, Inc. | Preparation d'une emulsion grasse contenant du propofol |
| WO2006030450A2 (fr) * | 2004-09-13 | 2006-03-23 | Bharat Serums & Vaccines Ltd. | Compositions d'emulsions stables destinees a l'administration intraveineuse et presentant une efficacite de conservation |
| AU2006310044A1 (en) * | 2005-08-12 | 2007-05-10 | Bharat Serums & Vaccines Ltd. | Aqueous anaesthetic compositions comprising propofol |
| WO2007128866A2 (fr) * | 2006-05-09 | 2007-11-15 | Novobion Oy | Nouvelles compositions chimiques |
| US8563221B2 (en) * | 2008-03-11 | 2013-10-22 | 3M Innovative Properties Company | Phototools having a protective layer |
| WO2010148288A2 (fr) * | 2009-06-19 | 2010-12-23 | Lyotropic Therapeutics, Inc. | Formulations pharmaceutiques avec de faibles taux aqueux de médicament non lié libre |
| CN102597116B (zh) | 2009-07-21 | 2013-12-11 | 3M创新有限公司 | 可固化组合物、涂覆底片的方法、以及被涂覆的底片 |
| WO2011034847A1 (fr) | 2009-09-16 | 2011-03-24 | 3M Innovative Properties Company | Revêtement fluore et creations photographiques a base de ce revêtement |
| CN102549042B (zh) | 2009-09-16 | 2015-01-28 | 3M创新有限公司 | 氟化涂料和用其制作的底片 |
| US8268067B2 (en) * | 2009-10-06 | 2012-09-18 | 3M Innovative Properties Company | Perfluoropolyether coating composition for hard surfaces |
| EP2345427A1 (fr) * | 2010-01-14 | 2011-07-20 | SapioTec GmbH | Complexe de flurane |
| DK2484350T3 (en) * | 2011-02-04 | 2016-08-01 | Norbert Univ -Prof Dr Med Roewer | A pharmaceutical composition containing a complex of a cyclodextrin with a propofolsalt |
| AU2013273764B2 (en) * | 2011-11-29 | 2016-05-05 | Zoetis Services Llc | Pharmaceutical compositions |
| DK2785352T3 (da) * | 2011-11-29 | 2020-05-25 | Jurox Pty Ltd | Stabile injicerbare farmaceutiske sammensætninger omfattende 2-hydroxypropyl-beta-cyclodextrin og alfaxalon |
| CN103263404B (zh) * | 2012-04-28 | 2017-12-01 | 中国人民解放军军事医学科学院放射与辐射医学研究所 | 一种复合麻醉药物 |
| WO2017132243A1 (fr) * | 2016-01-29 | 2017-08-03 | Cuda Anesthetics, Llc | Formulation pharmaceutique aqueuse comprenant du propofol |
| FR3117337B1 (fr) | 2020-12-10 | 2023-04-28 | Centre Hospitalier Univ De Lille | Composition pharmaceutique contenant du propofol, une cyclodextrine ou un dérivé de cyclodextrine et un sel pharmaceuticalement acceptable |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA962214B (en) * | 1995-04-10 | 1996-10-07 | Farmarc Nederland Bv | Pharmaceutical composition |
-
2000
- 2000-06-21 IN IN573MU2000 patent/IN187686B/en unknown
- 2000-12-14 BR BR0017268-5A patent/BR0017268A/pt not_active Application Discontinuation
- 2000-12-14 NZ NZ523643A patent/NZ523643A/en not_active IP Right Cessation
- 2000-12-14 DE DE60011149T patent/DE60011149T2/de not_active Expired - Lifetime
- 2000-12-14 EA EA200300047A patent/EA005589B1/ru not_active IP Right Cessation
- 2000-12-14 WO PCT/IN2000/000124 patent/WO2001097796A1/fr active IP Right Grant
- 2000-12-14 ES ES00991825T patent/ES2222271T3/es not_active Expired - Lifetime
- 2000-12-14 US US10/296,765 patent/US7138387B2/en not_active Expired - Lifetime
- 2000-12-14 AU AU2001235972A patent/AU2001235972B2/en not_active Ceased
- 2000-12-14 AP APAP/P/2002/002674A patent/AP2002002674A0/en unknown
- 2000-12-14 CN CNB008198292A patent/CN1254237C/zh not_active Expired - Fee Related
- 2000-12-14 DK DK00991825T patent/DK1299095T3/da active
- 2000-12-14 JP JP2002503273A patent/JP4907833B2/ja not_active Expired - Fee Related
- 2000-12-14 IL IL15338700A patent/IL153387A0/xx not_active IP Right Cessation
- 2000-12-14 YU YU2703A patent/YU2703A/sh unknown
- 2000-12-14 PL PL00359624A patent/PL359624A1/xx unknown
- 2000-12-14 MX MXPA02012611A patent/MXPA02012611A/es active IP Right Grant
- 2000-12-14 CA CA2414064A patent/CA2414064C/fr not_active Expired - Fee Related
- 2000-12-14 EP EP00991825A patent/EP1299095B1/fr not_active Expired - Lifetime
- 2000-12-14 AT AT00991825T patent/ATE267592T1/de active
- 2000-12-14 PT PT00991825T patent/PT1299095E/pt unknown
- 2000-12-14 HU HU0301646A patent/HUP0301646A3/hu unknown
- 2000-12-14 KR KR1020027017362A patent/KR100810066B1/ko not_active IP Right Cessation
- 2000-12-14 AU AU3597201A patent/AU3597201A/xx active Pending
-
2002
- 2002-12-13 NO NO20025999A patent/NO20025999L/no not_active Application Discontinuation
-
2003
- 2003-01-13 ZA ZA200300336A patent/ZA200300336B/en unknown
- 2003-01-16 BG BG107463A patent/BG107463A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20025999D0 (no) | Klart, vandig anestetisk preparat | |
| BR0111206A (pt) | Derivados de arilmetilamina para uso como inibidores de triptase | |
| UY26635A1 (es) | Métodos sinérgicos y composiciones para el tratamiento del cáncer | |
| RS51304B (sr) | Farmaceutske kompozicije neuroaktivnog steroida i njihova upotreba | |
| AR053162A1 (es) | Compuesto 5 - oxo - pirrolidin sustituido, composicion farmaceutica que lo comprende y su uso para preparar un medicamento para el tratamiento del glaucoma. | |
| SE0001899D0 (sv) | New compounds | |
| CY1111433T1 (el) | Φαρμακευτικο τυποποιημενο παρασκευασμα δεσιταβινης | |
| TW200700093A (en) | Pharmaceutical composition for the treatment of cancer | |
| BR0008590A (pt) | Agente de entrega polimérico, composição, formade unidade de dosagem, método para administrarum agente biologicamente ativo a um animalnecessitando o agente, método para preparar umacomposição; e composto | |
| BR9813811A (pt) | "composições farmacêuticas compreendendo micelas que compreendem glicocorticosteróide lipofìlico e apenas um único tensoativo" | |
| UA91512C2 (ru) | Коньюгати олигомеров инсулина, их композиция (варианты) и применение | |
| BR0214343A (pt) | Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1 | |
| RS20050066A (en) | Aqueous 2,6-diisopropylphenol pharmaceutical compositions | |
| ATE430564T1 (de) | Stabile pharmazeutische zusammensetzungen aus antitumoralen platin-(ii)-mitteln | |
| BRPI0508540A (pt) | composto, composição farmacêutica, e, uso de um composto | |
| HRP20030046B1 (en) | Pharmaceutical compositions for the treatment of mucositis, stomatitis and behcet's syndrome | |
| BRPI0414428A (pt) | composições farmacêuticas | |
| BR0109672A (pt) | Uso de zd6126 ou de um seu sal farmaceuticamente aceitável e um de: um agente antitumoral de plantina e um taxano, composição farmacêutica, produto de combinação, kit, e, método para a produção de um efeito de danificação vascular em um animal de sangue quente | |
| WO2007056263A3 (fr) | Methodes de traitement anticancereux avec des formulations d'un compose de platine a base de lipides d'une haute activite administrees par voie intraveineuse | |
| UA93365C2 (ru) | Инъекционная форма диклофенака и его фармацевтически приемлемых солей (варианты) и способ его приготовления (варианты) | |
| ES2105923B1 (es) | Composiciones para el tratamiento de una infeccion y una enfermedad causadas por el virus de la hepatitis b (hbv). | |
| AR028987A1 (es) | Compuesto derivado de ciclopentapiridin-cetona, composicion farmaceutica que lo contiene y su uso en la fabricacion de un medicamento util para tratar una enfermedad | |
| AR063111A1 (es) | Una formulacion farmaceutica de taxano | |
| BR0210063A (pt) | Composição estável e uso da mesma | |
| AR038017A1 (es) | Composicion anestesica acuosa y clara |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |